Skip to main content
SpringerLink
Log in

Abbott and the WHO have agreed on a balanced approach to deliver Kaletra/Aluvia [lopinavir/ritonavir]

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Abbott.Abbott Agrees With World Health Organization (WHO) Director-General to Expand Access to Kaletra/Aluvia (lopinavir/ritonavir). Media Release: 10 Apr 2007. Available from: URL: http://www.abbott.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abbott and the WHO have agreed on a balanced approach to deliver Kaletra/Aluvia [lopinavir/ritonavir]. Pharmacoecon. Outcomes News 526, 11 (2007). https://doi.org/10.2165/00151234-200705260-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705260-00028

Keywords

Search

Navigation